Product assistance program

Vanessa has congenital factor XIII deficiency; Ohio, USA

Novo Nordisk can help people get the treatment they want

People with congenital factor XIII A-subunit deficiency may be able to get help with treatment costs through the Novo Nordisk Hemophilia and Rare Bleeding Disorder Product Assistance Program (PAP). Individuals may be eligible if they:

  • Have been prescribed a Novo Nordisk factor product
  • Are currently uninsured
  • Have no options for alternate coverage
  • Have a gap in coverage

Click here to download the PAP application.

Co-pay assistance program

Through the Novo Nordisk Co-pay Assistance Program, eligible patients receive up to $12,000 per year toward their co-pay for Novo Nordisk Hemophilia and Rare Bleeding Disorder products. Patients may be eligible if they:

  • Have been prescribed a Novo Nordisk factor product
  • Are currently privately/commercially insured

Click here to apply for co-pay insurance.

HCP resources for ordering Tretten®

Click here if you are a healthcare provider (HCP) interested in ordering Tretten®. This information is intended for use only by HCPs in the United States.

Patient support program

NovoSecureTM—personalized patient support for every step of life's journey

Through NovoSecureTM, people have access to personalized support specifically designed for and inspired by the bleeding disorders community, including:

  • Insurance and educational support
  • Resources to help keep people educated and healthy
  • One-on-one access to a NovoSecure™ Specialist

Click here or call 1-844-NOVOSEC (1-844-668-6732) to learn more and enroll.

Novo Nordisk product usage is not an eligibility requirement of NovoSecure™.